ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

121–140 of 220 studies

E2 ModerateCohortPEM unclearObservational

Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole.

Crosby, L D, Kalanidhi, S, Bonilla, A et al.·Journal of translational medicine·2021

This study looked back at medical records of 101 ME/CFS patients who were prescribed a low dose of aripiprazole, a medication typically used for other conditions. The researchers found that some patients reported improvements in their symptoms. While these results are encouraging, the study design means we need to be cautious about how much weight to give these findings.

Evidence Atlas

Evidence browser

Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole.

The Relationship Between Childhood Trauma and the Response to Group Cognitive-Behavioural Therapy for Chronic Fatigue Syndrome.

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study.

Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: outcomes from a specialist clinic in the UK.

General theory of inflammation: patient self-administration of hydrocortisone safely achieves superior control of hydrocortisone-responding disorders by matching dosage with symptom intensity.

Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome.

Symptoms of chronic fatigue syndrome/myalgic encephalopathy are not determined by activity pacing when measured by the chronic pain coping inventory.

Why do some ME/CFS patients benefit from treatment with sodium dichloroacetate, but others do not?

Long-term follow-up after cognitive behaviour therapy for chronic fatigue syndrome.

Cognitive behaviour therapy for chronic fatigue syndrome: Differences in treatment outcome between a tertiary treatment centre in the United Kingdom and the Netherlands.

Chronic fatigue syndrome: comparing outcomes in White British and Black and minority ethnic patients after cognitive-behavioural therapy.

Group Cognitive Behaviour Therapy for Chronic Fatigue Syndrome.

A UK based review of recommendations regarding the management of chronic fatigue syndrome.

Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome.

Outcomes and predictors of response from an optimised, multidisciplinary intervention for chronic fatigue states.

The role of the partner and relationship satisfaction on treatment outcome in patients with chronic fatigue syndrome.

Functional level of patients with chronic fatigue syndrome reporting use of alternative vs. traditional treatments.

Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia.

Adolescent chronic fatigue syndrome and somatoform disorders: a prospective clinical study.

Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research